CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 31.04% | -8.49% | — | |
| 2 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 29.52% | -0.16% | — | |
| 3 | JBIO | Jade Biosciences INC | Stock-Other | 18.56% | -0.43% | — | |
| 4 | SKYE | Skye Bioscience INC | Stock-Other | 10.22% | -0.13% | — | |
| 5 | RPTX | Repare Therapeutics INC | Stock-Other | 4.48% | — | — | |
| 6 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 2.62% | +0.90% | -40.90% | |
| 7 | OVASUSD | Tempest Therapeutics INC | Stock-Other | 2.23% | -0.20% | — | |
| 8 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 1.33% | — | — |